靶点- |
作用机制- |
在研机构- |
|
在研适应症- |
|
最高研发阶段终止 |
首次获批国家/地区- |
首次获批日期- |
Phase I, Pilot Study in Healthy Volunteers, to Assess the Safety and Pharmacokinetics of PCO-02, Which Active Ingredient is BPC-157, a Penta-deca-peptide From Gastric Source.
Phase I clinical trial in healthy volunteers to study safety and pharmacokinetics of BPC-157, a pentadecapeptide from gastric source.
100 项与 PHARMACOTHERAPIA D.O.O. 相关的临床结果
0 项与 PHARMACOTHERAPIA D.O.O. 相关的专利(医药)
100 项与 PHARMACOTHERAPIA D.O.O. 相关的药物交易
100 项与 PHARMACOTHERAPIA D.O.O. 相关的转化医学